Published Date: 08 Mar 2023
Medicare covers people with disabilities who are young enough to get pregnant. Contraception is often not covered for these patients and they opt for hysterectomy or tubal ligation, which may be covered.
Read Full NewsNovartis plans to submit regulatory applications for ianalumab in early 2026.
Pulmonary arterial hypertension treatment continues to evolve with new therapies and strategies.
If approved, lecanemab-irmb would provide an at-home subcutaneous injection option for both treatment initiation and maintenance dosing for patients with early-stage Alzheimer disease.
A recent study linked maternal diabetes to a doubled risk of multiple sclerosis in offspring, highlighting prenatal factors in MS susceptibility.
Head-to-head PET imaging data indicated that valbenazine achieves significantly higher VMAT2 target occupancy than deutetrabenazine XR at therapeutic doses, with both treatments remaining well tolerated.
The FDA raised no objections to Lexicon Pharmaceuticals’ pilavapadin for a phase 3 program, which will include 2-arm registrational studies, in patients with diabetic peripheral neuropathic pain.
McGill emphasizes new exciting data shared at ACR 2025.
1.
New tumor therapy approach reduces costs and side effects while increasing accessibility
2.
Obesity-related cancer rising among both younger and older adults worldwide, study finds
3.
AI-based liquid biopsy shows promise for detecting brain cancer
4.
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
5.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
1.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
2.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Exploring the Hope of New Treatments for Rhabdomyosarcoma
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation